Patient Priorities for Survivorship Care in Older Breast Cancer Survivors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Dana E. Giza, MD
The University of Texas Health Science Center, Houston
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ut Physicians Center for Healthy Aging Bellaire
Bellaire, Texas, United States
Recruiting - Memorial Hermann Cancer Center
Houston, Texas, United States
Dana E Giza, MDRecruiting - Ut Physicians Family Medicine Bayshore
Houston, Texas, United States
Dana E Giza, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Jan 2025
- Primary completion
- 1 Dec 2026
- Completion
- 1 Jun 2027
- Last update posted
- 12 Aug 2025
- Registered enrollment
- 120
- Registry id
- NCT06478589
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.